About
Technology
Issues
FAQ
Links
Official Page
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.